<!DOCTYPE html>
<html>
<head>
  <title>Roshan Lodha CV</title>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <link rel="stylesheet" href="./assets/cv.css">
</head>
<body>
  <header>
    <h1>Roshan Lodha</h1>
    <p>
      <a href="mailto:lodhar@ccf.org">lodhar@ccf.org</a> | <a href="tel:510-779-8518">(510) 779-8518</a> | <a href="https://github.com/roshanlodha">github.com/roshanlodha</a>
    </p>
  </header>
  <main>
    <section>
      <h2>Education</h2>
      <hr>
      <ul>
        <li>Doctor of Medicine, <i>Cleveland Clinic Lerner College of Medicine, 2026</i></li>
        <li>Master of Science in Biomedical Engineering, <i>Case Western Reserve University, 2026</i></li>
        <li>Bachelor of Arts in Computer Science, <i>University of California - Berkeley, 2021</i></li>
        <li>Bachelor of Arts in Biochemistry & Molecular Biology, <i>University of California - Berkeley, 2021</i></li>
      </ul>
    </section>
    <section>
      <h2>Research Experience</h2>
      <hr>
      <ul>
        <li>Cancer Data Science Lab, NIH, Bethesda, MD
          <ul>
            <li><i>2024 - present</i></li>
            <li>Mentor: Eytan Ruppin, M.D., Ph.D.</li>
          </ul>
        </li>
        <li>Chung Lab, Cleveland Clinic Foundation
          <ul>
            <li><i>2021-present</i></li>
            <li>Mentors: Mina Chung, M.D. and John Barnard, Ph.D.</li>
          </ul>
        </li>
        <li>Gladson Lab, Lerner Research Institute
          <ul>
            <li><i>2021-2024</i></li>
            <li>Mentor: Candece Gladson, M.D.</li>
          </ul>
        </li>
        <li>Feng Lab, University of California, San Francisco
          <ul>
            <li><i>2018-2021</i></li>
            <li>Mentors: Jonathan Chou, M.D., Ph.D. and Felix Feng, M.D.</li>
          </ul>
        </li>
      </ul>
    </section>
    <section>
      <h2>Projects</h2>
      <hr>
      <ul>
        <li>Non-random Rotation Matching Algorithm (NRMA)
          <ul>
            <li><i>2023</i></li>
            <li><a href="https://github.com/roshanlodha/NRMA" target="_blank">github.com/roshanlodha/NRMA</a></li>
          </ul>
        </li>
        <li>NBMErepeater
          <ul>
            <li><i>2024</i></li>
            <li><a href="https://roshanlodha.pythonanywhere.com" target="_blank">roshanlodha.pythonanywhere.com</a></li>
          </ul>
        </li>
      </ul>
    </section>
    <section>
      <h2>Publications</h2>
      <hr>
      <ul>
        <li>Shulman ED, Campagnolo EM, <b>Lodha R</b>, Hu T, Nasrallah M, Hoang DT, et al. Path2Space: A deep learning model for predicting spatial gene expression from histopathology slides enabling scalable biomarker discovery and precision oncology. <i>In preparation</i>.</li>
        <li>Chang K, Delavan H, Yip E, Kasap C, Zhu J, <b>Lodha R</b>, et al. Modulating the PPARγ pathway upregulates NECTIN4 and enhances chimeric antigen receptor (CAR) T cell therapy in bladder cancer. <i>Under review</i>.</li>
        <li>Shen A, Arbesman M, <b>Lodha R</b>, Rayman P, Gastman B, Ko J, et al. Germline pathogenic variant (gPV) positive patients with melanoma exhibit improved response to checkpoint inhibitor immunotherapy. <i>Under review</i>.</li>
        <li><b>Lodha R</b>, Muller-Greven G, Maqbool MA, Guo L, Buchan G, Desai K, et al. Transcriptomic changes in glioblastoma predict a poor response to bevacizumab therapy: A novel therapeutic target for resistant tumors. <i>Under review</i>.</li>
        <li>Chou J, Robinson TM, Egusa EA, <b>Lodha R</b>, Zhang M, Badura ML, et al. Synthetic lethal targeting of cyclin dependent kinase-12-deficient prostate cancer with PARP inhibitors. <i>Clinical Cancer Research</i>. Accepted.</li>
        <li>Shen A, Arbesman M, <b>Lodha R</b>, Rayman P, Bungo B, Ni Y, et al. Clinical and Immunologic Features of Germline Pathogenic Variant–Positive Patients with Melanoma. <i>Clinical Cancer Research</i>. 2024;30(3):564–74. </li>
        <li><b>Lodha R</b>, Mehta N, Nielsen C. Non-random Rotation Matching Algorithm. <i>medRxiv</i>. 2023;2023–08. </li>
      </ul>
    </section>
    <section>
      <h2>Selected Presentations</h2>
      <hr>
      <ul>   
        <li>Chang K, Delavan HM, Zhu J, Kasap C, Yip E, <b>Lodha R</b>, et al. Abstract PR008: Modulating the PPARγ pathway to augment NECTIN4-targeting chimeric antigen receptor (CAR) T cell therapy. Clinical Cancer Research. 2024;30(10_Supplement):PR008–PR008. </li>
        <li>Shen A, <b>Lodha R</b>, Bungo B, Arbesman M, Pramod N, Ko J, et al. Germline variant positive melanoma patients exhibit an enhanced inflammatory microenvironment. Cancer Research. 2023;83(7_Supplement):5963–5963.</li>
        <li>Pramod N, Dawsey S, Pavicic PG, <b>Lodha R</b>, Patgunarajah U, Nair M, et al. Characterizing immune-genomic signatures associated with response to immune checkpoint inhibitors (ICI) in patients with metastatic urothelial carcinoma (mUC). 2023;</li>
        <li><b>Lodha R</b>, Muller-Greven G, Guo L, Gladson C. Glioblastoma tumors that respond poorly to bevacizumab therapy show upregulation of an angiogenesis gene set. Cancer Research. 2023;83(7_Supplement):4593–4593. </li>
      </ul>
    </section>
    <section>
      <h2>Awards</h2>
      <hr>
      <ul>
        <li>Honors in Molecular & Cell Biology, UC Berkeley, 2021</li>
        <li>Leadership Award, Cal Alumni Association, 2017-2021</li>
        <li>Full tuition scholarship, Cleveland Clinic Lerner College of Medicine, 2021-2026</li>
        <li>Medical Research Scholars Program, NIH Clinical Center, 2024-2025</li>
      </ul>
    <section>
      <h2>Teaching Experience</h2>
      <hr>
      <ul>
        <li>Course Facilitator - DeCal, University of California, Berkeley, <i>Jan 2021 - May 2021</i></li>
        <li>Undergraduate Instructor - MCBC100A, University of California, Berkeley, <i>May 2019 - Jan 2021</i></li>
        <li>Academic Intern - CS61A, University of California, Berkeley, <i>May 2018 - Aug 2018</i></li>
      </ul>
    </section>
    <section>
      <h2>Work Experience</h2>
      <hr>
      <ul>
        <li>Sports Medicine Intern, University of California, Berkeley, <i>Aug 2018 - May 2019</i></li>
      </ul>
    </section>
    <section>
      <h2>Organizations and Leadership</h2>
      <hr>
      <ul>
        <li>Co-president - Oncology Student Interest Group of CCLCM, <i>2021-2023</i></li>
        <li>Co-president - Medical Reallocation Initiative of CWRU SOM, <i>2021-2023</i></li>
        <li>Co-president - CaseMed Tech, <i>2022-2023</i></li>
        <li>Senior Advisor - Data Science Society, <i>Jan 2021 - May 2021</i></li>
        <li>Directory of Academic Development - Data Science Society, <i>May 2020 - Dec 2020</i></li>
        <li>President - Medical Reallocation Initiative, <i>May 2020 - May 2021</i></li>
        <li>Chief Technology Officer - Medical Reallocation Initiative, <i>May 2018 - May 2020</i></li>
      </ul>
    </section>
  </main>
</body>
</html>
